Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Non-Hodgkin Lymphoma
Condition(s):Lymphoma, Non-Hodgkin Lymphoma, B-CellLast Updated:January 13, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Lymphoma, Non-Hodgkin Lymphoma, B-CellLast Updated:January 13, 2023Recruiting
Condition(s):COVID-19; SARS-CoV-2; Furin; RGMc Processing; Paired Basic Amino Acid Cleaving Enzyme (PACE)Last Updated:March 29, 2023Terminated
Condition(s):Bacterial VaginosisLast Updated:December 28, 2018Completed
Condition(s):Breast Cancer; BRCA1 Mutation; BRCA2 MutationLast Updated:July 9, 2019Completed
Condition(s):MindfulnessLast Updated:July 17, 2020Completed
Condition(s):Atherosclerosis; Cardiovascular DiseaseLast Updated:June 4, 2012Completed
Condition(s):Respiratory DiseaseLast Updated:January 5, 2021Unknown status
Condition(s):Advanced Colorectal Carcinoma; Liver Metastasis Colon CancerLast Updated:June 6, 2022Recruiting
Condition(s):Bladder CancerLast Updated:March 23, 2022Active, not recruiting
Condition(s):Hemorrhagic Fever, EbolaLast Updated:March 7, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.